11/13/2024

Clonazepam Oral Tablets

Products Affected - Description

- Clonazepam oral tablet, Accord, 0.5 mg, bottle, 100 count, NDC 16729-0136-00
- Clonazepam oral tablet, Accord, 0.5 mg, bottle, 500 count, NDC 16729-0136-16
- Clonazepam oral tablet, Accord, 1 mg, bottle, 100 count, NDC 16729-0137-00
- Clonazepam oral tablet, Accord, 1 mg, bottle, 500 count, NDC 16729-0137-16
- Clonazepam oral tablet, Accord, 2 mg, bottle, 100 count, NDC 16729-0138-00
- Clonazepam oral tablet, Accord, 2 mg, bottle, 500 count, NDC 16729-0138-16
- Clonazepam oral tablet, Solco Healthcare US, 0.5 mg, bottle, 100 count, NDC 43547-0406-10
- Clonazepam oral tablet, Solco Healthcare US, 0.5 mg, bottle, 500 count, NDC 43547-0406-50
- Clonazepam oral tablet, Solco Healthcare US, 0.5 mg, bottle, 1000 count, NDC 43547-0406-11
- Clonazepam oral tablet, Solco Healthcare US, 1 mg, bottle, 100 count, NDC 43547-0407-10
- Clonazepam oral tablet, Solco Healthcare US, 1 mg, bottle, 500 count, NDC 43547-0407-50
- Clonazepam oral tablet, Solco Healthcare US, 1 mg, bottle, 1000 count, NDC 43547-0407-11
- Clonazepam oral tablet, Solco Healthcare US, 2 mg, bottle, 100 count, NDC 43547-0408-10
- Clonazepam oral tablet, Solco Healthcare US, 2 mg, bottle, 500 count, NDC 43547-0408-50
- Clonazepam oral tablet, Teva, 0.5 mg, bottle, 100 count, NDC 00093-0832-01
- Clonazepam oral tablet, Teva, 0.5 mg, bottle, 500 count, NDC 00093-0832-05
- Clonazepam oral tablet, Teva, 1 mg, bottle, 100 count, NDC 00093-3212-01
- Clonazepam oral tablet, Teva, 2 mg, bottle, 100 count, NDC 00093-3213-01

Reason for the Shortage

- Accord has clonazepam tablets on back order due to a manufacturing issue.
- H2 Pharma has Klonopin available.
- Solco did not provide a reason for the shortage.
- Teva has clonazepam on shortage due to increased demand.

Available Products

- Klonopin oral tablet, H2 Pharma, 0.5 mg, bottle, 100 count, NDC 61269-0605-10
- Klonopin oral tablet, H2 Pharma, 1 mg, bottle, 100 count, NDC 61269-0610-10
- Klonopin oral tablet, H2 Pharma, 2 mg, bottle, 100 count, NDC 61269-0620-10
- Clonazepam oral tablet, Teva, 2 mg, bottle, 500 count, NDC 00093-3213-05

Estimated Resupply Dates

- Accord has all clonazepam tablets on intermittent back order and the company is releasing supplies as they become available.
- Solco has all presentations on allocation.
- Teva has clonazepam 0.5 mg tablets in 100 count and 500 count bottles, 1 mg tablets in 100 count bottles, and 2 mg tablets in 100 count bottles on intermittent back order and the company is releasing supplies as they become available.

Updated

Updated November 13, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created April 10, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.